Loading…
Loading…
See exactly how LABD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LABD and 80,000+ other tickers.
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push toward addressing the human condition — which is often found to be shockingly frail.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Market volatility boosts demand for leveraged and inverse-leveraged ETFs. A few of them gained more than 25% last month.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Inverse and volatility ETFs won in the worst week of Wall Street since 2020.